Haiyang, L., Li, S., Song, Y., Jiang, C., Pan, J., Hu, X. (2026). First-in-human novel bispecific epitope anti-CD5 nanobody CAR-T cells for refractory or relapsed T-cell malignancies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7015